|
1
|
Mellon RD, Simone AF and Rappaport BA: Use
of anesthetic agents in neonates and young children. Anesth Analg.
104:509–520. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brambrink AM, Evers AS, Avidan MS, Farber
NB, Smith DJ, Martin LD, Dissen GA, Creeley CE and Olney JW:
Ketamine-induced neuroapoptosis in the fetal and neonatal rhesus
macaque brain. Anesthesiology. 116:372–384. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li J, Wang B, Wu H, Yu Y, Xue G and Hou Y:
17β-estradiol attenuates ketamine-induced neuroapoptosis and
persistent cognitive deficits in the developing brain. Brain Res.
1593:30–39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu F, Patterson TA, Sadovova N, Zhang X,
Liu S, Zou X, Hanig JP, Paule MG, Slikker W Jr and Wang C:
Ketamine-induced neuronal damage and altered N-methyl-D-aspartate
receptor function in rat primary forebrain culture. Toxicol Sci.
131:548–557. 2013. View Article : Google Scholar :
|
|
5
|
Li J, Wu H, Xue G, Wang P and Hou Y:
17β-Oestradiol protects primary-cultured rat cortical neurons from
ketamine-induced apoptosis by activating PI3K/Akt/Bcl-2 signalling.
Basic Clin Pharmacol Toxicol. 113:411–418. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Melcangi RC, Garcia-Segura LM and
Mensah-Nyagan AG: Neuroactive steroids: State of the art and new
perspectives. Cell Mol Life Sci. 65:777–797. 2008. View Article : Google Scholar
|
|
7
|
Panzica GC, Balthazart J, Frye CA,
Garcia-Segura LM, Herbison E, Mensah-Nyagan AG, McCarthy MM and
Melcangi RC: Milestones on steroids and the nervous system: 10
years of basic and translational research. J Neuroendocrinol.
24:1–15. 2012. View Article : Google Scholar
|
|
8
|
Schumacher M, Hussain R, Gago N, Oudinet
JP, Mattern C and Ghoumari AM: Progesterone synthesis in the
nervous system: Implications for myelination and myelin repair.
Front Neurosci. 6:102012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hirst JJ, Kelleher MA, Walker DW and
Palliser HK: Neuroactive steroids in pregnancy: Key regulatory and
protective roles in the foetal brain. J Steroid Biochem Mol Biol.
139:144–153. 2014. View Article : Google Scholar
|
|
10
|
Mellon SH: Neurosteroid regulation of
central nervous system development. Pharmacol Ther. 116:107–124.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
De Olmos S, Bueno A, Bender C, Lorenzo A
and de Olmos J: Sex differences and influence of gonadal hormones
on MK801-induced neuronal degeneration in the granular
retro-splenial cortex of the rat. Brain Struct Funct. 213:229–238.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Caldeira JC, Wu Y, Mameli M, Purdy RH, Li
PK, Akwa Y, Savage DD, Engen JR and Valenzuela CF: Fetal alcohol
exposure alters neurosteroid levels in the developing rat brain. J
Neurochem. 90:1530–1539. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Trickler WJ, Guo X, Cuevas E, Ali SF,
Paule MG and Kanungo J: Ketamine attenuates cytochrome p450
aromatase gene expression and estradiol-17β levels in zebrafish
early life stages. J Appl Toxicol. 34:480–488. 2014. View Article : Google Scholar
|
|
14
|
Kanungo J, Cuevas E, Ali SF and Paule MG:
Ketamine induces motor neuron toxicity and alters neurogenic and
proneural gene expression in zebrafish. J Appl Toxicol. 33:410–417.
2013. View
Article : Google Scholar
|
|
15
|
Wang C, Sadovova N, Fu X, Schmued L,
Scallet A, Hanig J and Slikker W: The role of the
N-methyl-D-aspartate receptor in ketamine-induced apoptosis in rat
forebrain culture. Neuroscience. 132:967–977. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kawato S: Endocrine disrupters as
disrupters of brain function: A neurosteroid viewpoint. Environ
Sci. 11:1–14. 2004.
|
|
17
|
Hudson AE and Hemmings HC Jr: Are
anaesthetics toxic to the brain? Br J Anaesth. 107:30–37. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vutskits L, Gascon E and Kiss JZ: Effects
of ketamine on the developing central nervous system. Ideggyogy Sz.
60:109–112. 2007.PubMed/NCBI
|
|
19
|
Liu F, Paule MG, Ali S and Wang C:
Ketamine-induced neurotoxicity and changes in gene expression in
the developing rat brain. Curr Neuropharmacol. 9:256–261. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duan X, Li Y, Zhou C, Huang L and Dong Z:
Dexmedetomidine provides neuroprotection: impact on
ketamine-induced neuroapoptosis in the developing rat brain. Acta
Anaesthesiol Scand. 58:1121–1126. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Belelli D and Lambert JJ: Neurosteroids:
Endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci.
6:565–575. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen G, Li HM, Chen YR, Gu XS and Duan S:
Decreased estradiol release from astrocytes contributes to the
neurodegeneration in a mouse model of Niemann-Pick disease type C.
Glia. 55:1509–1518. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nagarajan G, Aruna A and Chang CF:
Neurosteroidogenic enzymes and their regulation in the early brain
of the protogynous grouper Epinephelus coioides during gonadal sex
differentiation. Gen Comp Endocrinol. 181:271–287. 2013. View Article : Google Scholar
|
|
24
|
McCarthy MM: Estradiol and the developing
brain. Physiol Rev. 88:91–124. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tanaka M and Sokabe M: Continuous de novo
synthesis of neurosteroids is required for normal synaptic
transmission and plasticity in the dentate gyrus of the rat
hippocampus. Neuropharmacology. 62:2373–2387. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suzuki S, Kiyosue K, Hazama S, Ogura A,
Kashihara M, Hara T, Koshimizu H and Kojima M: Brain-derived
neurotrophic factor regulates cholesterol metabolism for synapse
development. J Neurosci. 27:6417–6427. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Frank C, Rufini S, Tancredi V, Forcina R,
Grossi D and D'Arcangelo G: Cholesterol depletion inhibits synaptic
transmission and synaptic plasticity in rat hippocampus. Exp
Neurol. 12:407–414. 2008. View Article : Google Scholar
|
|
28
|
Goritz C, Mauch DH and Pfrieger FW:
Multiple mechanisms mediate cholesterol-induced synaptogenesis in a
CNS neuron. Mol Cell Neurosci. 29:190–201. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ortiz JB, McLaughlin KJ, Hamilton GF,
Baran SE, Campbell AN and Conrad CD: Cholesterol and perhaps
estradiol protect against corticosterone-induced hippocampal CA3
dendritic retraction in gonadectomized female and male rats.
Neuroscience. 246:409–421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McLaughlin KJ, Wilson JO, Harman J, Wright
RL, Wieczorek L, Gomez J, Korol DL and Conrad CD: Chronic
17beta-estradiol or cholesterol prevents stress-induced hippocampal
CA3 dendritic retraction in ovariectomized female rats: Possible
correspondence between CA1 spine properties and spatial
acquisition. Hippocampus. 20:768–786. 2010.
|
|
31
|
Li L, Xiao N, Yang X, Gao J, Ding J, Wang
T, Hu G and Xiao M: A high cholesterol diet ameliorates
hippocampus-related cognitive and pathological deficits in
ovariectomized mice. Behav Brain Res. 230:251–258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grewal AK, Jaggi AS, Rana AC and Singh N:
Effect of neurosteroid modulation on global
ischaemia-reperfusion-induced cerebral injury in mice. Korean J
Physiol Pharmacol. 17:485–491. 2013. View Article : Google Scholar
|
|
33
|
Fiocchetti M, Ascenzi P and Marino M:
Neuroprotective effects of 17β-estradiol rely on estrogen receptor
membrane initiated signals. Front Physiol. 3:732012. View Article : Google Scholar
|
|
34
|
Schaeffer V, Patte-Mensah C, Eckert A and
Mensah-Nyagan AG: Modulation of neurosteroid production in human
neuroblastoma cells by Alzheimer's disease key proteins. J
Neurobiol. 66:868–881. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Marx CE, Trost WT, Shampine LJ, Stevens
RD, Hulette CM, Steffens DC, Ervin JF, Butterfield MI, Blazer DG,
Massing MW, et al: The neurosteroid allopregnanolone is reduced in
prefrontal cortex in Alzheimer's disease. Biol Psychiatry.
60:1287–1294. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yue X, Lu M, Lancaster T, Cao P, Honda S,
Staufenbiel M, Harada N, Zhong Z, Shen Y and Li R: Brain estrogen
deficiency accelerates Abeta plaque formation in an Alzheimer's
disease animal model. Proc Natl Acad Sci USA. 102:19198–19203.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schaeffer V, Patte-Mensah C, Eckert A and
Mensah-Nyagan AG: Selective regulation of neurosteroid biosynthesis
in human neuroblastoma cells under hydrogen peroxide-induced
oxidative stress condition. Neuroscience. 151:758–770. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vierk R, Brandt N and Rune GM: Hippocampal
estradiol synthesis and its significance for hippocampal synaptic
stability in male and female animals. Neuroscience. 274:24–32.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lupp A, Kerst S and Karge E: Evaluation of
possible pro- or antioxidative properties and of the interaction
capacity with the microsomal cytochrome P450 system of different
NMDA-receptor ligands and of taurine in vitro. Exp Toxicol Pathol.
54:441–448. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lephart ED, Adlercreutz H and Lund TD:
Dietary soy phytoestrogen effects on brain structure and aromatase
in Long-Evans rats. Neuroreport. 12:3451–3455. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Garcia-Ovejero D, Azcoitia I, Doncarlos
LL, Melcangi RC and Garcia-Segura LM: Glia-neuron crosstalk in the
neuroprotective mechanisms of sex steroid hormones. Brain Res Brain
Res Rev. 48:273–286. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Morale MC, L'Episcopo F, Tirolo C,
Giaquinta G, Caniglia S, Testa N, Arcieri P, Serra PA, Lupo G,
Alberghina M, et al: Loss of aromatase cytochrome P450 function as
a risk factor for Parkinson's disease? Brain Res Brain Res Rev.
57:431–443. 2008. View Article : Google Scholar
|
|
43
|
Simpson ER: Models of aromatase
insufficiency. Semin Reprod Med. 22:25–30. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pierman S, Sica M, Allieri F,
Viglietti-Panzica C, Panzica GC and Bakker J: Activational effects
of estradiol and dihydrotestosterone on social recognition and the
arginine-vasopressin immunoreactive system in male mice lacking a
functional aromatase gene. Horm Behav. 54:98–106. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hill RA, Simpson ER and Boon WC: Evidence
for the existence of an estrogen-responsive sexually dimorphic
group of cells in the medial preoptic area of the 129SvEv mouse
strain. Int J Impot Res. 20:315–323. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sasahara K, Shikimi H, Haraguchi S,
Sakamoto H, Honda S, Harada N and Tsutsui K: Mode of action and
functional significance of estrogen-inducing dendritic growth,
spinogenesis, and synaptogenesis in the developing Purkinje cell. J
Neurosci. 27:7408–7417. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fester L, Ribeiro-Gouveia V, Prange-Kiel
J, Von Schassen C, Böttner M, Jarry H and Rune GM: Proliferation
and apoptosis of hippocampal granule cells require local oestrogen
synthesis. J Neurochem. 97:1136–1144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hero M, Maury S, Luotoniemi E, Service E
and Dunkel L: Cognitive effects of aromatase inhibitor therapy in
peripubertal boys. Eur J Endocrinol. 163:149–155. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Garcia-Segura LM, Veiga S, Sierra A,
Melcangi RC and Azcoitia I: Aromatase: A neuroprotective enzyme.
Prog Neurobiol. 71:31–41. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Azcoitia I, Sierra A, Veiga S, Honda S,
Harada N and Garcia-Segura LM: Brain aromatase is neuroprotective.
J Neurobiol. 47:318–329. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Veiga S, Azcoitia I and Garcia-Segura LM:
Extragonadal synthesis of estradiol is protective against kainic
acid excitotoxic damage to the hippocampus. Neuroreport.
16:1599–1603. 2005. View Article : Google Scholar : PubMed/NCBI
|
